Donepezil

Critical Warnings & Restrictions

Basic Donepezil Information

• INN (International Nonproprietary Name): Donepezil
• Brand Names Available In United Kingdom: Aricept; Aricept Evess; Donepezil Teva; Donepezil Mylan; Donepezil Sandoz
• ATC Code: N06DA02
• Forms & Dosages: Film-coated tablets 5mg and 10mg; Orodispersible tablets (ODT) 5mg and 10mg; Extended-release transdermal patch 5mg/24hr and 10mg/24hr (available in some regions); Donepezil + memantine combination capsules available internationally
• Manufacturers In United Kingdom: not specified
• Registration Status In United Kingdom: Registered with MHRA
• OTC / Rx Classification: Prescription-Only (Rx)

High-Risk Groups

Donepezil is prescribed mainly for older adults with Alzheimer’s disease.

Known hypersensitivity to donepezil hydrochloride or piperidine derivatives is an absolute contraindication.

Use extreme caution in patients with cardiac conduction abnormalities such as sick sinus syndrome.

Exercise caution if the patient has asthma or chronic obstructive pulmonary disease.

A history of peptic ulcer disease or current anticoagulant/NSAID use increases gastrointestinal bleed risk.

Urinary outflow obstruction and seizure disorders require careful assessment before starting donepezil.

Pregnancy and lactation: data are limited so avoid unless benefit clearly outweighs risk and consult obstetric services.

• Use Checklist For In-Clinic Review:
• Baseline ECG
• Respiratory review (asthma/COPD history)
• History of gastrointestinal bleeding or peptic ulcer disease
• Seizure history and neurology input if present
• Medication reconciliation including OTC and herbal products

Interaction With Activities

Donepezil can cause dizziness, drowsiness, blurred vision, syncope and bradycardia.

Patients should be counselled about the risk of falls and fainting, especially during initiation and dose increases.

Under UK law, patients with dementia must inform the DVLA when their condition affects driving safety.

Clinicians should document the driving advice given to each patient.

Advise not to undertake safety-critical tasks, including certain work duties, if symptomatic.

Q&A — “Can I Drive After Taking It In The UK?”

• Q: Can I drive after taking donepezil?
• A: Only if you feel safe.
• If you experience dizziness, fainting, marked drowsiness or visual disturbance do not drive and inform your GP and the DVLA as required.
• Documented cognitive decline from dementia often triggers DVLA reporting; always check NHS.UK and DVLA guidance.
• Immediate Actions Checklist:
• Stop driving immediately if you faint or have repetitive dizziness.
• Contact your GP for urgent review.
• Report new syncope or falls to your healthcare team.

Usage Basics

INN, Brand Names Available In The UK

Donepezil is the International Nonproprietary Name used across clinical practice.

Common UK-supplied brands and generics include Aricept, Aricept Evess and EU generics such as Donepezil Teva, Donepezil Mylan and Donepezil Sandoz.

Formulations on the market include film-coated tablets and orodispersible tablets (ODT) in 5mg and 10mg strengths.

Transdermal systems such as Adlarity and international combination products with memantine exist, but check MHRA licence status locally.

Legal Classification (POM, P, GSL)

• Donepezil Is A Prescription-Only Medicine (POM) Throughout The United Kingdom.
• Dispensing Under NHS Prescriptions Uses FP10 In England, Wales And Northern Ireland Or NHS Arrangements In Scotland.
• Pharmacists Must Follow GPhC Standards For Counselling And Record-Keeping.

INN

Donepezil

POM

Prescription-Only Medicine

ODT

Orodispersible Tablet

Dosing Guide

Standard Regimens

The usual starting dose for adults with Alzheimer’s disease is 5mg once daily, commonly taken at bedtime.

After 4–6 weeks, if tolerated, the dose is often increased to 10mg once daily.

The standard maximum oral dose in many regions is 10mg daily.

Extended-release 23mg formulations exist in some countries but are less commonly used in the UK.

Donepezil is intended as a long-term symptomatic treatment and requires regular review for benefit and harms.

Adjustments For Comorbidities

• No routine renal dose adjustment is required due to minimal renal excretion.
• Use caution in severe hepatic impairment and consider closer monitoring or lower threshold for stopping treatment.
• Not recommended for children; safety and efficacy not established.

Q&A — “What If I Miss A Dose?”

• Q: Missed dose—what to do?
• A: Take the next scheduled dose at the usual time; do NOT double up.
• If it is close to the next dose, skip the missed dose and continue as normal.
• Contact GP or pharmacist if multiple missed doses occur or if withdrawal-like symptoms are suspected.

• Titration Monitoring Checklist:
• Record heart rate and blood pressure at baseline and during titration.
• Monitor weight and appetite.
• Ask about gastrointestinal symptoms such as nausea or diarrhoea.
• Check adherence and provide support such as ODT or pill organisers.

Interaction Chart

Food And Drinks

Alcohol may increase dizziness and the risk of falls, particularly during initiation and dose changes.

Advise limiting alcohol until individual tolerance is clear.

There is no clinically important interaction with ordinary caffeine intake, but monitor for sleep disturbance or agitation.

Common Drug Conflicts

• Action And Counselling Summary:
• Record all medicines including OTC and herbal products.
• Warn about additive bradycardia with beta-blockers or calcium antagonists.
• Consider gastroprotection if NSAIDs are required.
• Report suspected interactions to the MHRA Yellow Card scheme.

User Reports & Trends

Patients and carers commonly report early gastrointestinal side effects such as nausea and diarrhoea when starting donepezil.

Vivid dreams and sleep disturbance are frequent complaints in patient forums and NHS patient pages.

Some carers note modest stabilisation in memory and attention rather than dramatic improvements.

Adherence can be affected when tablets provoke nausea, prompting dose breaks or switching formulations.

• Common Themes From Patient Reports:
• Early GI effects: nausea, vomiting, diarrhoea
• Sleep changes: insomnia or vivid dreams
• Small cognitive or functional stabilisation in some patients
• Preference for orodispersible tablets or transdermal options to ease administration

• Caregiver Monitoring Checklist:
• Monitor appetite and weight weekly in the early weeks.
• Record any falls, faints or unexplained dizziness.
• Note sleep patterns and dream disturbances.
• Contact pharmacist for dose-related side effects and consider reporting to Yellow Card.

Access & Purchase Options

High-Street Pharmacies

Donepezil is dispensed in person at major chains such as Boots, LloydsPharmacy and Superdrug under an NHS prescription or privately where permitted.

Pharmacists provide counselling at supply and can arrange repeat dispensing and compliance aids.

Generics and branded packs such as Aricept are commonly stocked; typical pack sizes include 28-tablet blister cards.

Online Pharmacies And NHS E-Prescriptions

Electronic Prescription Service (EPS) simplifies repeat supplies and many registered online pharmacies will dispense after a valid prescription.

Always verify that an online seller is GPhC registered and that products carry MHRA-approved licences.

Avoid unregulated international suppliers and check manufacturer names such as Pfizer, Eisai, Teva, Sandoz and Mylan.

• Checks Before Ordering Online:
• Confirm GPhC registration and pharmacy address.
• Verify MHRA licence or product packaging details.
• Use secure payment methods and check privacy policies.

In our online pharmacy, donepezil is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Mechanism & Pharmacology

Simplified Explanation

Donepezil is a centrally acting reversible acetylcholinesterase inhibitor.

It slows the breakdown of acetylcholine in the brain and temporarily enhances cholinergic neurotransmission.

That mechanism can modestly improve cognition, behaviour and function in Alzheimer’s disease for some patients.

Clinical Terms

Acetylcholinesterase Inhibitor

A drug that blocks the enzyme which breaks down acetylcholine.

ODT

Orodispersible Tablet, dissolves on the tongue for easier swallowing.

POM

Prescription-Only Medicine.

Indications & Off-Label Uses

MHRA-Approved Uses

• Primary approved use is symptomatic treatment of Alzheimer’s disease, typically in mild to moderate cases.
• Use donepezil as part of a broader dementia care plan including non-drug interventions.
• Combination products with memantine exist internationally; check UK licensing for specific products.

Off-Label Practices In NHS And Private Care

Off-label use may be considered for Parkinson’s disease dementia and dementia with Lewy bodies where cholinesterase inhibitors can benefit cognition and visual hallucinations.

Such use requires specialist assessment and careful weighing of benefit versus risk.

• Checklist For Specialist Referral And Consent:
• Document clinical rationale and expected outcomes.
• Obtain informed consent and record discussion in notes.
• Arrange baseline assessments and a review plan with secondary care.

Key Clinical Findings

Systematic reviews and meta-analyses show donepezil provides modest but clinically relevant improvements in cognition and global clinical impression in mild to moderate Alzheimer’s disease.

Benefits on activities of daily living are smaller and evidence for disease modification is lacking.

ODT and transdermal formulations can improve tolerability and adherence and may reduce gastrointestinal adverse events in some trials.

Combination therapy with memantine can add benefit in moderate to severe disease in some studies.

• Key Outcomes To Communicate:
• Modest cognitive improvement for some patients.
• Small effect on daily living activities.
• No clear disease-modifying effect.
• Formulation changes can improve GI tolerability and ease administration.

References To Consult For Clinicians: NICE guidance, Cochrane reviews and MHRA product information.

Alternatives Matrix

NHS Prescribing Alternatives

Pros And Cons Checklist

• Donepezil Pros: Once-daily dosing, solid evidence base, generics widely available.
• Donepezil Cons: Gastrointestinal side effects, bradycardia risk, no disease-modifying effect.

Common Questions

• Q: Will donepezil stop my dementia getting worse?
• A: No — it may temporarily improve cognition or slow decline for some people, but it is not disease-modifying.
• Q: How soon will I see an effect?
• A: Some patients notice changes within weeks; a standard review is at 6–12 weeks after titration to judge benefit.
• Q: Can carers administer and crush tablets?
• A: Orodispersible tablets can help with swallowing; crushing some film-coated tablets may be unsuitable so check the SPC and ask the pharmacist.
• Q: What are the main side effects?
• A: Nausea, diarrhoea, insomnia, vivid dreams, muscle cramps; bradycardia and syncope are less common but important.

• When To Contact The GP Checklist:
• Persistent or severe gastrointestinal symptoms.
• Any fainting, syncope or unexplained falls.
• Marked bradycardia or palpitations.
• New or worsening seizures.

NHS Cost & Access Comparison Table

• Checklist For Exemption Documentation:
• Bring pension or entitlement letters for free prescriptions.
• Provide NHS number or ID when collecting prescriptions.
• Pharmacies will check entitlement at the point of dispensing.

Registration & Regulation

MHRA Approval Process

The MHRA issues marketing authorisations for medicinal products for UK use and oversees pharmacovigilance requirements.

Donepezil branded and generic products are subject to MHRA licensing and safety monitoring.

Suspected adverse reactions should be reported via the MHRA Yellow Card scheme.

NHS Prescribing Framework

• Prescribing should follow NICE guidance and local formulary recommendations.
• GPs should document indication, expected outcomes and review schedule in records.
• Shared care agreements with secondary care are common for dementia treatments.

• Clinician Checklist:
• Obtain informed consent and document it.
• Perform baseline checks such as ECG if indicated.
• Agree follow-up timing and who will review the patient.
• Record any DVLA driving advice in the notes.

Storage & Handling

UK Household Storage

Store donepezil at room temperature between 15–30°C and keep dry and away from direct light.

Avoid storing medicines in the bathroom due to humidity variations.

Keep medicines in their original packaging to retain expiry and batch details.

Keep out of reach and sight of children and vulnerable adults.

Guidance From NHS And Pharmacists

• When Travelling: Keep medicines in hand luggage and avoid extreme temperatures for long periods.
• Disposal: Return unused or expired medication to a pharmacy for safe disposal; do not flush medicines down the toilet.
• Transdermal Patch Disposal: Fold sticky sides together before disposal to avoid accidental exposure.

Expiry

Check the date on original packaging and do not use beyond this date.

Batch Information

Keep packaging until you no longer need batch details for adverse-event reporting.

Guidelines For Proper Use

UK Pharmacist Counselling Style

Pharmacists should cover the INN and brand names, dosing schedule and route of administration.

Explain expected benefits and a realistic timeline for response.

Describe common and serious side effects and what to do about them.

Check for interactions with prescription, OTC and herbal medicines.

Advise on missed doses and emergency actions for overdose, noting that IV atropine is used as an antidote per product information.

Emphasise DVLA responsibilities regarding driving for patients with dementia.

NHS Patient Safety Advice

• Document a review schedule at 6–12 weeks after initiation or dose change, then periodically thereafter.
• Monitor weight, appetite, heart rate and falls.
• Consider ECG monitoring if cardiac conduction disease is suspected.
• Switch to ODT or patch if there are swallowing difficulties or persistent GI intolerance.
• Shared care agreements should clarify responsibilities between primary and secondary care.

• Dispensing And Follow-Up Checklist:
• Confirm identity and prescription validity before supply.
• Provide a simple patient handout stating dose, common side effects and emergency contacts.
• Record counselling in the pharmacy record and offer contact details for follow-up.

Delivery Across United Kingdom